| 000 | 01018 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513062645.0 | ||
| 264 | 0 | _c19940503 | |
| 008 | 199405s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.308.6930.717 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSzarewski, A | |
| 245 | 0 | 0 |
_aDepot medroxyprogesterone acetate and osteoporosis. Monitor serum oestradiol concentration in users. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cMar 1994 |
||
| 300 |
_a717 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 |
_aEstradiol _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadverse effects |
| 650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
| 700 | 1 | _aHollingworth, B | |
| 700 | 1 | _aGuillebaud, J | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 308 _gno. 6930 _gp. 717 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.308.6930.717 _zAvailable from publisher's website |
| 999 |
_c8142132 _d8142132 |
||